Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration A Randomized Phase 2 Trial

Overview of attention for article published in Ophthalmology, July 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 9 news stories from 6 outlets.

(Image Credit: AdobeStock/bukhta79) Age-related macular degeneration (AMD) is a potentially vision-threatening disease, with…

Staging AMD accurately and identifying clinical features that are linked with disease progression are key.

The complement system identifies and eliminates pathogens and dying cells, 3 pathways can activate the complement system—classica…

For nearly 20 years, neovascular age-related macular degeneration (AMD) has been getting all the attention as a result of the…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 5 additional news stories.